ADMA Biologics Inc (ADMA) - Financial and Strategic SWOT Analysis Review

November 2021 | 48 pages | ID: A0028AEE17EEN
GlobalData

Abstracts

ADMA Biologics Inc (ADMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ADMA Biologics Inc (ADMA Biologics) is an integrated biopharmaceutical and specialty immunoglobulin company which develops, produces, and commercializes specialty biologics to treat immune deficiencies and prevent certain infectious diseases. The company develops Bivigam, a plasma-derived IVIG that contains a broad range of antibodies; and ASCENIV, a specialty plasma-derived, polyclonal, intravenous immune globulin, derived from human plasma containing naturally occurring polyclonal antibodies to treat Primary Immune Deficiency Disease. ADMA Biologics’ target treatment areas include bacterial infections, respiratory syncytial virus and primary immune deficiency diseases. It also operates bio centers which carry out plasma collection and offer blood plasma to manufacture the company’s products. ADMA Biologics is headquartered in Ramsey, New Jersey, the US.

ADMA Biologics Inc Key Recent Developments

Nov 16,2021: ADMA Biologics Advances Plasma Collection Center expansion plans with opening of new facility in Myrtle Beach, SC
Oct 18,2021: ADMA Biologics Strengthens its Board of Directors with the Appointment of Young T. Kwon, Ph.D.
Sep 23,2021: ADMA Biologics to Virtually Participate in the Cantor Healthcare Conference
Sep 08,2021: ADMA Biologics receives FDA approval for VanRx aseptic fill-finish machine and related operations
Aug 16,2021: ADMA Biologics receives FDA approval for ADMA BioCenters plasma collection facility in Maryville, TN

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

ADMA Biologics Inc - Key Facts
ADMA Biologics Inc - Key Employees
ADMA Biologics Inc - Key Employee Biographies
ADMA Biologics Inc - Major Products and Services
ADMA Biologics Inc - History
ADMA Biologics Inc - Company Statement
ADMA Biologics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
ADMA Biologics Inc - Business Description
Product Category: License Revenue
Performance
Product Category: Product Revenue
Performance
Product Category: ADMA BioManufacturing
Overview
Performance
Product Category: Corporate
Performance
Product Category: Plasma Collection Centers
Overview
Performance
R&D Overview
ADMA Biologics Inc - Corporate Strategy
ADMA Biologics Inc - SWOT Analysis
SWOT Analysis - Overview
ADMA Biologics Inc - Strengths
ADMA Biologics Inc - Weaknesses
ADMA Biologics Inc - Opportunities
ADMA Biologics Inc - Threats
ADMA Biologics Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
ADMA Biologics Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Nov 16, 2021: ADMA Biologics Advances Plasma Collection Center expansion plans with opening of new facility in Myrtle Beach, SC
Oct 18, 2021: ADMA Biologics Strengthens its Board of Directors with the Appointment of Young T. Kwon, Ph.D.
Sep 23, 2021: ADMA Biologics to Virtually Participate in the Cantor Healthcare Conference
Sep 08, 2021: ADMA Biologics receives FDA approval for VanRx aseptic fill-finish machine and related operations
Aug 16, 2021: ADMA Biologics receives FDA approval for ADMA BioCenters plasma collection facility in Maryville, TN
Aug 11, 2021: ADMA Biologics Reports Record Second Quarter 2021 Financial Results and Highlights Recent Progress and Accomplishments
Aug 10, 2021: ADMA Biologics advances expansion plans and opens new plasma collection center in Conyers, GA; ADMA Implements Haemonetics’ Persona Technology for NexSys Plasma Collection System
Aug 09, 2021: ADMA Biologics announces commercial availability of expanded vial size offerings for BIVIGAM and NABI-HB
May 12, 2021: ADMA Biologics Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress and Accomplishments
Apr 26, 2021: ADMA Biologics opens newest ADMA BioCenters plasma collection facility in Goose Creek, S.C.

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

ADMA Biologics Inc, Key Facts
ADMA Biologics Inc, Key Employees
ADMA Biologics Inc, Key Employee Biographies
ADMA Biologics Inc, Major Products and Services
ADMA Biologics Inc, History
ADMA Biologics Inc, Subsidiaries
ADMA Biologics Inc, Key Competitors
ADMA Biologics Inc, Ratios based on current share price
ADMA Biologics Inc, Annual Ratios
ADMA Biologics Inc, Annual Ratios (Cont...1)
ADMA Biologics Inc, Annual Ratios (Cont...2)
ADMA Biologics Inc, Interim Ratios
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
ADMA Biologics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

ADMA Biologics Inc, Performance Chart (2016 - 2020)
ADMA Biologics Inc, Ratio Charts
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021